291 related articles for article (PubMed ID: 27545845)
21. Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial.
Gogas BD; Serruys PW; Diletti R; Farooq V; Brugaletta S; Radu MD; Heo JH; Onuma Y; van Geuns RJ; Regar E; De Bruyne B; Chevalier B; Thuesen L; Smits PC; Dudek D; Koolen J; Windecker S; Whitbourn R; Miquel-Hebert K; Dorange C; Rapoza R; Garcia-Garcia HM; McClean D; Ormiston JA
JACC Cardiovasc Interv; 2012 Jun; 5(6):656-65. PubMed ID: 22721662
[TBL] [Abstract][Full Text] [Related]
22. Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation.
Opolski MP; Kepka C; Wojakowski W; Witkowski A
Clin Res Cardiol; 2019 Mar; 108(3):344-346. PubMed ID: 30182164
[No Abstract] [Full Text] [Related]
23. Intravascular ultrasound-guided drug-eluting stent implantation.
Kadohira T; Kobayashi Y
Cardiovasc Interv Ther; 2017 Jan; 32(1):1-11. PubMed ID: 27822889
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM
Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436
[TBL] [Abstract][Full Text] [Related]
25. A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up.
Serruys PW; Ormiston J; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Chevalier B; Smits P; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Wasungu L; Ediebah D; Veldhof S; Onuma Y
J Am Coll Cardiol; 2016 Feb; 67(7):766-76. PubMed ID: 26892411
[TBL] [Abstract][Full Text] [Related]
26. Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery.
Wu Y; Shen L; Ge L; Wang Q; Qian J; Zhang F; Yao K; Huang D; Chen Y; Ge J
Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():630-7. PubMed ID: 26864162
[TBL] [Abstract][Full Text] [Related]
27. Impact of coronary calcification on outcomes after ABSORB scaffold implantation: insights from the GABI-R registry.
Hemetsberger R; Abdelghani M; Mankerious N; Allali A; Toelg R; Gori T; Achenbach S; Riemer T; Mehilli J; Nef HM; Naber C; Wöhrle J; Zahn R; Kastner J; Schmermund A; Hamm C; Münzel T; Richardt G;
Coron Artery Dis; 2020 Nov; 31(7):578-585. PubMed ID: 32271247
[TBL] [Abstract][Full Text] [Related]
28. Intravascular Ultrasound for Guidance and Optimization of Percutaneous Coronary Intervention.
Mahtta D; Elgendy AY; Elgendy IY; Mahmoud AN; Tobis JM; Mojadidi MK
Interv Cardiol Clin; 2018 Jul; 7(3):315-328. PubMed ID: 29983144
[TBL] [Abstract][Full Text] [Related]
29. Role of invasive imaging in acute and long-term assessment of bioresorbable scaffold technology.
Chamié D; Garcia-Garcia H; Costa RA; Onuma Y; Abizaid A; Serruys PW
Catheter Cardiovasc Interv; 2016 Nov; 88(S1):38-53. PubMed ID: 27797463
[TBL] [Abstract][Full Text] [Related]
30. Serial intravascular ultrasound evaluation of the DESolve™ novolimus-eluting bioresorbable coronary scaffold system.
Barreira G; Costa JR; Costa R; Staico R; Chamie D; Slhessarenko JR; Tanajura LF; Abizaid A; Sousa A; Abizaid A
Catheter Cardiovasc Interv; 2018 Nov; 92(6):E368-E374. PubMed ID: 29521477
[TBL] [Abstract][Full Text] [Related]
31. Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study.
Fam JM; Felix C; Ishibashi Y; Onuma Y; Diletti R; Van Mieghem NM; Regar E; De Jaegere P; Zijlstra F; van Geuns RJM
Int J Cardiol; 2017 Dec; 249():119-126. PubMed ID: 28943146
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention).
Maehara A; Ben-Yehuda O; Ali Z; Wijns W; Bezerra HG; Shite J; Généreux P; Nichols M; Jenkins P; Witzenbichler B; Mintz GS; Stone GW
JACC Cardiovasc Interv; 2015 Nov; 8(13):1704-14. PubMed ID: 26585621
[TBL] [Abstract][Full Text] [Related]
33. Effect of Plaque Composition, Morphology, and Burden on DESolve Novolimus-Eluting Bioresorbable Vascular Scaffold Expansion and Eccentricity - An Optical Coherence Tomography Analysis.
Boeder NF; Dörr O; Bauer T; Elsässer A; Möllmann H; Achenbach S; Hamm CW; Nef HM
Cardiovasc Revasc Med; 2019 Jun; 20(6):480-484. PubMed ID: 30638889
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of intravascular ultrasound to predict outcomes in short-length lesions treated with drug-eluting stents.
Yoon YW; Shin S; Kim BK; Kim JS; Shin DH; Ko YG; Choi D; Jeon DW; Kwon H; Jang Y; Hong MK;
Am J Cardiol; 2013 Sep; 112(5):642-6. PubMed ID: 23711810
[TBL] [Abstract][Full Text] [Related]
35. Impact of Strut Width in Periprocedural Myocardial Infarction: A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent.
Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Naganuma T; Sticchi A; Figini F; Latib A; Chieffo A; Carlino M; Montorfano M; Colombo A
JACC Cardiovasc Interv; 2015 Jun; 8(7):900-9. PubMed ID: 26003020
[TBL] [Abstract][Full Text] [Related]
36. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes following bioresorbable scaffold implantation for bifurcation lesions: Overall outcomes and comparison between provisional and planned double stenting strategy.
Kawamoto H; Latib A; Ruparelia N; Miyazaki T; Sticchi A; Naganuma T; Sato K; Figini F; Chieffo A; Carlino M; Montorfano M; Colombo A
Catheter Cardiovasc Interv; 2015 Oct; 86(4):644-52. PubMed ID: 26013748
[TBL] [Abstract][Full Text] [Related]
38. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.
Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D
JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648
[TBL] [Abstract][Full Text] [Related]
39. Minimal Acute Recoil Following Bioresorbable Scaffold Implantation in Fibrocalcific Lesion Detected by Optical Frequency-Domain Imaging.
Kawamoto H; Ruparelia N; Tanaka A; Latib A; Colombo A
J Invasive Cardiol; 2016 Mar; 28(3):E34-6. PubMed ID: 26945257
[TBL] [Abstract][Full Text] [Related]
40. Calcification analysis by intravascular ultrasound to define a predictor of left circumflex narrowing after cross-over stenting for unprotected left main bifurcation lesions.
Sato K; Naganuma T; Costopoulos C; Takebayashi H; Goto K; Miyazaki T; Yamane H; Hagikura A; Kikuta Y; Taniguchi M; Hiramatsu S; Latib A; Ito H; Haruta S; Colombo A
Cardiovasc Revasc Med; 2014 Mar; 15(2):80-5. PubMed ID: 24684758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
